XOMA - 30 Year Stock Price History | XOMA

Historical daily share price chart and data for XOMA since 1989 adjusted for splits. The latest closing stock price for XOMA as of June 14, 2019 is 16.78.
  • The all-time high XOMA stock price is 9600.00, which is 57111% above the current share price.
  • The XOMA 52-week high stock price is 25.73, which is 53.3% above the current share price.
  • The XOMA 52-week low stock price is 11.27, which is 32.8% below the current share price.
  • The average XOMA stock price for the last 52 weeks is 15.97.
XOMA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 14.1878 13.2700 18.9800 11.8300 16.7800 32.65%
2018 21.2280 35.9200 35.9200 11.2700 12.6500 -64.47%
2017 12.5470 4.9700 36.7900 4.0300 35.6000 743.60%
2016 12.4726 26.8000 26.8000 4.2200 4.2200 -84.14%
2015 50.2669 71.0000 94.4000 14.4120 26.6000 -62.95%
2014 100.2528 138.4000 188.8000 68.6000 71.8000 -46.66%
2013 81.3167 51.8000 146.0000 50.2000 134.6000 180.42%
2012 53.9870 25.0000 79.0000 24.8000 48.0000 108.70%
2011 57.1240 106.0000 146.1000 22.0000 23.0000 -77.58%
2010 118.3929 209.9700 238.2000 45.6000 102.6000 -51.06%
2009 218.8690 201.0000 354.0000 114.0000 209.6400 12.71%
2008 601.7336 960.0000 960.0000 180.0000 186.0000 -81.71%
2007 933.5940 648.0000 1281.0000 603.0000 1017.0000 54.09%
2006 557.9221 501.0000 732.0000 477.0000 660.0000 37.50%
2005 482.2155 768.0000 768.0000 297.0000 480.0000 -38.22%
2004 1180.6810 2010.0000 2292.0000 588.0000 777.0000 -60.76%
2003 1812.6256 1203.0000 2946.0000 876.0000 1980.0000 56.03%
2002 1763.6631 2802.0000 3525.0000 929.7000 1269.0000 -57.06%
2001 3004.7190 2625.0000 5118.0000 1668.9000 2955.0000 1.03%
2000 2422.9321 890.7000 4539.0000 843.9000 2925.0000 225.00%
1999 1225.2321 1012.5000 2353.2000 618.9000 900.0000 -5.90%
1998 1217.4488 1706.4000 1837.5000 590.7000 956.4000 -42.69%
1997 1792.3601 1509.3000 2418.9000 1181.4000 1668.9000 8.44%
1996 1527.6978 1200.0000 2400.0000 937.5000 1539.0000 46.57%
1995 734.3607 815.7000 1181.4000 393.9000 1050.0000 30.21%
1994 1066.2020 1650.0000 1800.0000 675.0000 806.4000 -48.80%
1993 2022.4530 3000.0000 3000.0000 1500.0000 1575.0000 -45.45%
1992 4560.1949 6114.0000 7350.0000 2700.0000 2887.5000 -54.17%
1991 6763.7905 6000.0000 9600.0000 4275.0000 6300.0000 2.44%
1990 6056.3597 7089.0000 7800.0000 4650.0000 6150.0000 -5.75%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.146B $0.005B
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Celgene (CELG) United States $68.065B 11.53
Illumina (ILMN) United States $50.568B 58.60
Biogen (BIIB) United States $44.144B 8.38
Vertex Pharmaceuticals (VRTX) United States $43.597B 52.70
Regeneron Pharmaceuticals (REGN) United States $33.355B 15.68
Alexion Pharmaceuticals (ALXN) United States $26.444B 14.97
Incyte (INCY) United States $16.664B 67.57
BioMarin Pharmaceutical (BMRN) United States $14.476B 0.00
Exact Sciences (EXAS) United States $14.177B 0.00
Seattle Genetics (SGEN) United States $11.050B 0.00
QIAGEN (QGEN) Netherlands $8.912B 29.27
Sarepta Therapeutics (SRPT) United States $8.867B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.674B 45.98
Bio-Techne Corp (TECH) United States $7.890B 53.83
Guardant Health (GH) United States $7.737B 0.00
Alnylam Pharmaceuticals (ALNY) United States $7.461B 0.00
Array BioPharma (ARRY) United States $6.562B 0.00
Bluebird Bio (BLUE) United States $6.486B 0.00
Galapagos (GLPG) Belgium $6.209B 0.00
Amarin (AMRN) Ireland $5.979B 0.00
Exelixis (EXEL) United States $5.945B 15.15
BeiGene (BGNE) Cayman Islands $5.486B 0.00
Ascendis Pharma (ASND) Denmark $5.094B 0.00
Moderna (MRNA) United States $5.067B 0.00
Blueprint Medicines (BPMC) United States $4.431B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.006B 0.00
Spark Therapeutics (ONCE) United States $3.753B 0.00
China Biologic Products (CBPO) China $3.650B 23.18
Repligen (RGEN) United States $3.505B 87.32
ACADIA Pharmaceuticals (ACAD) United States $3.497B 0.00
Alkermes (ALKS) Ireland $3.435B 0.00
Mirati Therapeutics (MRTX) United States $3.398B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.285B 0.00
Allogene Therapeutics (ALLO) United States $3.212B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.136B 0.00
Global Blood Therapeutics (GBT) United States $3.045B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.796B 0.00
UniQure (QURE) Netherlands $2.742B 0.00
Arena Pharmaceuticals (ARNA) United States $2.742B 5.57
Amicus Therapeutics (FOLD) United States $2.616B 0.00
Medicines (MDCO) United States $2.607B 0.00
Reata Pharmaceuticals (RETA) United States $2.452B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.369B 0.00
Immunomedics (IMMU) United States $2.367B 0.00
Lion Biotechnologies (IOVA) United States $2.359B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.289B 0.00
Halozyme Therapeutics (HALO) United States $2.289B 0.00
Emergent Biosolutions (EBS) United States $2.229B 19.36
NeoGenomics (NEO) United States $2.204B 144.31
MyoKardia (MYOK) United States $2.129B 0.00
Ligand Pharmaceuticals (LGND) United States $2.112B 17.49
Akcea Therapeutics (AKCA) United States $2.110B 0.00
Acceleron Pharma (XLRN) United States $1.983B 0.00
Genomic Health (GHDX) United States $1.896B 40.27
AnaptysBio (ANAB) United States $1.882B 0.00
Insmed (INSM) United States $1.848B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.829B 0.00
Allakos (ALLK) United States $1.812B 0.00
Denali Therapeutics (DNLI) United States $1.786B 0.00
REGENXBIO (RGNX) United States $1.768B 0.00
Myriad Genetics (MYGN) United States $1.762B 17.53
Audentes Therapeutics (BOLD) United States $1.681B 0.00
Cambrex (CBM) United States $1.443B 18.24
Innoviva (INVA) United States $1.429B 3.95
Alector (ALEC) United States $1.388B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.387B 0.00
Apellis Pharmaceuticals (APLS) United States $1.339B 0.00
Gossamer Bio (GOSS) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.293B 0.00
Aimmune Therapeutics (AIMT) United States $1.250B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.249B 0.00
Athenex (ATNX) United States $1.194B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.181B 0.00
Fate Therapeutics (FATE) United States $1.162B 0.00
Eidos Therapeutics (EIDX) United States $1.157B 0.00
Rubius Therapeutics (RUBY) United States $1.107B 0.00
Sangamo Therapeutics (SGMO) United States $1.074B 0.00
Editas Medicine (EDIT) United States $1.070B 0.00
Epizyme (EPZM) United States $1.056B 0.00
Atara Biotherapeutics (ATRA) United States $1.012B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.008B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.005B 0.00
Codexis (CDXS) United States $0.952B 0.00
NGM Biopharmaceuticals (NGM) United States $0.906B 0.00
RA PHARMCTL INC (RARX) United States $0.899B 0.00
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
ANI Pharmaceuticals (ANIP) United States $0.850B 15.07
ZIOPHARM Oncology Inc (ZIOP) United States $0.847B 0.00
CORTEXYME INC (CRTX) United States $0.843B 0.00
Principia Biopharma (PRNB) United States $0.827B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.819B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.811B 0.00
Retrophin (RTRX) United States $0.796B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.779B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.773B 36.50
Cara Therapeutics (CARA) United States $0.770B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.770B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.763B 0.00
Axsome Therapeutics (AXSM) United States $0.760B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.748B 0.00
Kura Oncology (KURA) United States $0.711B 0.00
Vericel (VCEL) United States $0.704B 0.00
G1 THERAPEUTICS (GTHX) United States $0.696B 0.00
Twist Bioscience (TWST) United States $0.694B 0.00
Intra-Cellular Therapies (ITCI) United States $0.690B 0.00
Clovis Oncology (CLVS) United States $0.686B 0.00
Adverum Biotechnologies (ADVM) United States $0.686B 0.00
MeiraGTx Holdings (MGTX) United States $0.684B 0.00
Arvinas (ARVN) United States $0.669B 0.00
Zymeworks (ZYME) Canada $0.657B 0.00
Zealand Pharma (ZEAL) Denmark $0.654B 7.64
Precision BioSciences (DTIL) United States $0.653B 0.00
Intellia Therapeutics (NTLA) United States $0.635B 0.00
Myovant Sciences (MYOV) United Kingdom $0.627B 0.00
Cellectis (CLLS) France $0.620B 0.00
Stemline Therapeutics (STML) United States $0.619B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.619B 0.00
Heska (HSKA) United States $0.616B 63.08
Lexicon Pharmaceuticals (LXRX) United States $0.600B 0.00
Viking Therapeutics (VKTX) United States $0.566B 0.00
Anika Therapeutics (ANIK) United States $0.565B 19.31
Cytokineticsorporated (CYTK) United States $0.551B 0.00
Puma Biotechnology (PBYI) United States $0.495B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.490B 0.00
UROGEN PHARMA (URGN) United States $0.485B 0.00
DBV Technologies (DBVT) France $0.484B 0.00
Magenta Therapeutics (MGTA) United States $0.483B 0.00
Revance Therapeutics (RVNC) United States $0.478B 0.00
Mesoblast (MESO) Australia $0.477B 0.00
BeyondSpring (BYSI) United States $0.475B 0.00
CytomX Therapeutics (CTMX) United States $0.471B 0.00
ObsEva SA (OBSV) Switzerland $0.459B 0.00
Scholar Rock Holding (SRRK) United States $0.448B 0.00
Kodiak Sciences (KOD) United States $0.442B 0.00
Provention Bio (PRVB) United States $0.438B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.428B 0.00
Kaleido Biosciences (KLDO) $0.425B 0.00
Synthorx (THOR) United States $0.411B 0.00
MediciNova (MNOV) United States $0.402B 0.00
Replimune (REPL) United States $0.398B 0.00
AC Immune SA (ACIU) Switzerland $0.397B 25.57
Krystal Biotech (KRYS) United States $0.393B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.387B 0.00
Sorrento Therapeutics (SRNE) United States $0.386B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.385B 0.00
BioDelivery Sciences (BDSI) United States $0.382B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.377B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.375B 0.00
Prothena (PRTA) Ireland $0.375B 0.00
UNITY Biotechnology (UBX) $0.375B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.374B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Arcus Biosciences (RCUS) United States $0.369B 0.00
Acorda Therapeutics (ACOR) United States $0.362B 6.38
Agenus (AGEN) United States $0.357B 0.00
Senesco Technologies (ELOX) United States $0.352B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
PDL BioPharma (PDLI) United States $0.348B 8.31
NEXTCURE INC (NXTC) United States $0.341B 0.00
LogicBio Therapeutics (LOGC) United States $0.334B 0.00
AVROBIO (AVRO) United States $0.327B 0.00
ResTORbio (TORC) United States $0.320B 0.00
Merus (MRUS) Netherlands $0.305B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Kindred Biosciences (KIN) United States $0.302B 0.00
PHASEBIO PHARMA (PHAS) United States $0.285B 0.00
Geron (GERN) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.273B 0.00
Cyclerion Therapeutics (CYCN) United States $0.268B 0.00
Cellular Biomedicine (CBMG) United States $0.265B 0.00
XBiotech (XBIT) United States $0.258B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Abeona Therapeutics (ABEO) United States $0.254B 0.00
AXCELLA HEALTH (AXLA) United States $0.252B 0.00
Athersys (ATHX) United States $0.249B 0.00
Chiasma (CHMA) United States $0.248B 0.00
Dynavax Technologies (DVAX) United States $0.248B 0.00
Urovant Sciences (UROV) United States $0.243B 0.00
Inovio Pharmaceuticals (INO) United States $0.236B 0.00
Syros Pharmaceuticals (SYRS) United States $0.233B 0.00
Constellation Pharmaceuticals (CNST) United States $0.233B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.232B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.231B 0.00
Cerecor (CERC) United States $0.228B 0.00
Evelo Biosciences (EVLO) United States $0.225B 0.00
ChromaDex (CDXC) United States $0.225B 0.00
Neothetics (EVFM) United States $0.225B 0.00
Avid Bioservices (CDMO) United States $0.222B 0.00
Celcuity (CELC) United States $0.221B 0.00
Kamada (KMDA) Israel $0.221B 8.56
Kadmon Holdings (KDMN) United States $0.218B 0.00
ADMA Biologics Inc (ADMA) United States $0.217B 0.00
MannKind (MNKD) United States $0.216B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.213B 0.00
Five Prime Therapeutics (FPRX) United States $0.213B 0.00
IDEAYA BIOSCI (IDYA) United States $0.211B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.209B 0.00
Enochian BioSciences (ENOB) United States $0.205B 0.00
Affimed (AFMD) Germany $0.199B 0.00
Spero Therapeutics (SPRO) United States $0.198B 0.00
Synlogic (SYBX) United States $0.196B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.195B 0.00
Enzo Biochem (ENZ) United States $0.194B 0.00
HOOKIPA PHARMA (HOOK) United States $0.191B 0.00
Celyad SA (CYAD) Belgium $0.185B 0.00
VBI Vaccines (VBIV) United States $0.185B 0.00
Mersana Therapeutics (MRSN) United States $0.183B 0.00
Arsanis (XFOR) United States $0.181B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.178B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
Gamida Cell (GMDA) Israel $0.174B 0.00
Strongbridge Biopharma (SBBP) United States $0.174B 10.03
Compugen (CGEN) Israel $0.174B 0.00
Kala Pharmaceuticals (KALA) United States $0.173B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Kezar Life Sciences (KZR) United States $0.171B 0.00
OvaScience (MLND) United States $0.171B 0.00
Checkpoint Therapeutics (CKPT) United States $0.170B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
OSMOTICA PHARM (OSMT) United States $0.162B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Dyadic (DYAI) United States $0.158B 0.00
Intec Pharma (NTEC) Israel $0.155B 0.00
Anavex Life Sciences (AVXL) United States $0.154B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
APPLIED THERAPT (APLT) United States $0.146B 0.00
Aduro Biotech (ADRO) United States $0.143B 0.00
Mustang Bio (MBIO) United States $0.141B 0.00
TOCAGEN INC (TOCA) United States $0.138B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
TREVI THERAPTCS (TRVI) United States $0.134B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.124B 0.00
Aptose Biosciences (APTO) Canada $0.119B 0.00
Novavax (NVAX) United States $0.117B 0.00
Axovant Sciences (AXGT) United Kingdom $0.117B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.112B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.112B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
INmune Bio (INMB) United States $0.107B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.104B 0.00
Equillium (EQ) United States $0.104B 0.00
Verastem (VSTM) United States $0.103B 0.00
NantKwest (NK) United States $0.101B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.099B 0.00
Aptinyx (APTX) United States $0.099B 0.00
Trevena (TRVN) United States $0.098B 0.00
Selecta Biosciences (SELB) United States $0.094B 0.00
Seres Therapeutics (MCRB) United States $0.094B 0.00
Allena Pharmaceuticals (ALNA) United States $0.089B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
InflaRx (IFRX) Germany $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.077B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.075B 0.00
Cocrystal Pharma (COCP) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.074B 0.00
Unum Therapeutics (UMRX) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
Cohbar (CWBR) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
VTv Therapeutics (VTVT) United States $0.070B 0.00
OVID THERAPEUTC (OVID) United States $0.068B 0.00
Alcobra (ARCT) United States $0.068B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Hoth Therapeutics (HOTH) United States $0.063B 0.00
ScPharmaceuticals (SCPH) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
Eyenovia (EYEN) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Organovo Holdings (ONVO) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Ophthotech (ISEE) United States $0.054B 0.00
Moleculin Biotech (MBRX) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.051B 0.00
AEterna Zentaris (AEZS) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Bellerophon Therapeutics (BLPH) United States $0.043B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
Cidara Therapeutics (CDTX) United States $0.041B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Evogene (EVGN) Israel $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.033B 0.00
Edge Therapeutics (PDSB) United States $0.032B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Aytu Bioscience (AYTU) United States $0.029B 0.00
Histogenics (HSGX) United States $0.028B 0.00
Bison Capital Acquisition (XYN) China $0.027B 0.00
Sophiris Bio (SPHS) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
GTx (ONCT) United States $0.020B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.020B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Vical (VICL) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
OncoSec Medical (ONCS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
Advaxis (ADXS) United States $0.014B 0.00
Motif Bio Plc (MTFB) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Aileron Therapeutics (ALRN) United States $0.013B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
IMMURON LTD (IMRN) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.004B 0.00
Alliqua BioMedical (ADYX) United States $0.003B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00